Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study)

INTRODUCTION: This Italian multicenter retrospective study evaluated safety and efficacy of the anti-TNF drug, adalimumab, in a cohort of patients affected by tuberculosis (TB), hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV). Psoriasis is an autoimmune disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Narcisi, Alessandra, Bernardini, Nicoletta, Orsini, Diego, D’Agostino, Magda, De Felice, Catia, Di Stefani, Alessandro, Carboni, Valentina, Costanzo, Antonio, Mastroianni, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394150/
https://www.ncbi.nlm.nih.gov/pubmed/32792888
http://dx.doi.org/10.5114/ada.2020.96910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394150/
https://www.ncbi.nlm.nih.gov/pubmed/32792888
http://dx.doi.org/10.5114/ada.2020.96910

Ejemplares similares